Statistics for Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection
Total visits
| views | |
|---|---|
| Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection | 2 |
Total visits per month
| views | |
|---|---|
| diciembre 2024 | 0 |
| enero 2025 | 0 |
| febrero 2025 | 0 |
| marzo 2025 | 0 |
| abril 2025 | 0 |
| mayo 2025 | 1 |
| junio 2025 | 0 |
File Visits
| views | |
|---|---|
| 10.1177095632020701800201.pdf | 6 |